Sight Sciences financials
$9.35+0.86%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.4M | $19.7M | $20.4M | $19.9M | $19.6M | $17.5M | $19.1M | $20.2M | $21.4M | $19.3M | $18.8M | $20.0M |
| Gross profit | $21.4M | $17.0M | $17.8M | $17.2M | $16.6M | $15.1M | $16.6M | $16.9M | $18.3M | $16.5M | $16.0M | $17.3M |
| Gross margin | 91.4% | 86.2% | 87.3% | 86.4% | 84.8% | 86.2% | 86.8% | 83.9% | 85.8% | 85.5% | 85.2% | 86.6% |
| Operating income | -$3.9M | -$12.4M | -$3.7M | -$7.9M | -$11.7M | -$13.9M | -$11.9M | -$11.2M | -$12.7M | -$14.7M | -$11.1M | -$13.4M |
| Net income | -$4.4M | -$13.0M | -$4.2M | -$8.2M | -$11.9M | -$14.2M | -$11.8M | -$11.1M | -$12.3M | -$16.3M | -$10.7M | -$13.0M |
| Net margin | −19.0% | −65.9% | −20.4% | −41.0% | −61.0% | −80.8% | −62.1% | −54.9% | −57.7% | −84.4% | −57.0% | −65.1% |
| Diluted EPS | $-0.08 | $-0.24 | $-0.08 | $-0.16 | $-0.23 | $-0.28 | $-0.23 | $-0.22 | $-0.25 | $-0.33 | $-0.22 | $-0.27 |
| EBITDA | -$3.8M | -$12.3M | -$3.6M | -$7.8M | -$11.5M | -$13.7M | -$11.8M | -$11.1M | -$12.5M | -$14.5M | -$11.0M | -$13.3M |
| Operating cash flow | -$5.7M | -$7.0M | -$1.8M | -$8.7M | -$7.5M | -$11.6M | -$3.5M | $362.0K | -$9.5M | -$9.8M | -$6.5M | -$9.8M |
| Free cash flow | -$5.7M | -$7.1M | -$2.0M | -$8.9M | -$7.8M | -$11.6M | -$3.6M | $311.0K | -$9.5M | -$9.9M | -$6.7M | -$10.1M |
| Diluted shares | 54.5M | 53.9M | 53.1M | 52.4M | 51.8M | 51.3M | 50.8M | 50.3M | 49.9M | 49.5M | 48.9M | 48.7M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $79.8M | $85.0M | $92.0M | $92.4M | $101.5M | $108.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $40.8M | $40.5M | $40.3M | $40.1M | $39.8M | $39.6M |
| Total assets | $104.9M | $109.7M | $115.3M | $116.3M | $122.0M | $129.7M |
| Total liabilities | $52.0M | $55.8M | $51.4M | $52.0M | $52.0M | $52.1M |
| Shareholders' equity | $52.9M | $53.9M | $63.9M | $64.3M | $70.0M | $77.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology